Mycobacterium ulcerans disease, Peru

Emerging Infectious Diseases

Volumn 14, Issue 3, 2008, Pages 373-377

  Guerra, Humberto ^a   Palomino, Juan Carlos ^b   Falconí, Eduardo ^a,c   Bravo, Francisco ^a   Donaires, Ninoska ^a   Van Marck, Eric ^d   Portaels, Françoise ^b  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c INSTITUTO NACIONAL DE SALUD   (Peru)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DEXAMETHASONE; DISINFECTANT AGENT; ETHAMBUTOL; HERBACEOUS AGENT; MINOCYCLINE; RIFAMPICIN; STIBOGLUCONATE SODIUM; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIUM CULTURE; BURULI ULCER; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG WITHDRAWAL; EDUCATION PROGRAM; FEMALE; FINGER; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; LEG; LIVER TOXICITY; MALE; MYCOBACTERIUM ULCERANS; PERU; SWAMP; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION;

EID: 41349107811     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1403.070904     Document Type: Article

References (22)

1. Johnson PDR, Stinear TP, Small PLC, Pluschke G, Merritt RW, Portaels F, et al. Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PLoS Med. 2005;2:282-6.
2. van der Werf TS, Stienstra Y, Johnson R, Phillips R, Adjei O, Fleischer B, et al. Mycobacterium ulcerans disease (Buruli ulcer): a review. Bull World Health Organ. 2005;83:785-91.
3. Janssens PG, Pattyn SR, Meyers WM, Portaels F. Buruli ulcer: an historical overview with updating to 2005 [in French]. Bulletin des séances. Académie royale des Sciences d'outre-mer Bull. 2005;51:165-99.
4. Sizaire V, Nackers F, Comte E, Portaels F. Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis. 2006;6:288-96.
5. Portaels F, Meyers WM. Buruli ulcer. In: Faber WR, Hay RJ, Naafs B, editors. Imported skin diseases. Maarssen (the Netherlands): Elsevier Gezondheidszorg; 2006. pp. 117-29.
6. World Health Organization. Buruli ulcer disease. Mycobacterium ulcerans infection: an overview of reported cases globally. Wkly Epidemiol Rec. 2004;79:193-200.
7. Gallarday R, Gajate A, Mejía J, Saldaña J, Ruiz A. First cases of Buruli ulcer in Peru [in Spanish]. Sanidad Militar del Peru. 1969;42:59-74.
8. Saldaña-Patiño J. First findings of Buruli ulcer in Peru [in Spanish]. Acta Med Hosp Militar Central. 1988;5:55-74.
9. Asiedu K, Scherpbier R, Raviglione M. Ficha Médica para pacientes con úlcera de Buruli. In: Asiedu K, Scherpbier R, Raviglione M, editors. Buruli ulcer: Mycobacterium ulcerans infection. 1st ed. Geneva: World Health Organization; 2000. pp. 101-7.
10. World Health Organization. Buruli ulcer. Diagnosis of Mycobacterium ulcerans disease. In: Portaels F, Johnson P, Meyers WM, editors. WHO/CDS/GBUI/2001.4. Geneva: The Organization; 2001.
11. Eddyani M, Debacker M, Martin A, Aguiar J, Johnson RC, Uwizeye C, et al. Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in a semisolid transport medium. J Clin Microbiol. 2008;46:69-72.
12. World Health Organization. Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). Geneva: World Health Organization; 2004.
13. Portaels F, Guerra H. Úlcera de Buruli (Infección por Mycobacterium ulcerans). Buruli ulcer (infection by Mycobacterium ulcerans) diagnostic guide for health care workers [in Spanish]. Belgium: Directorate-General for International Cooperation; 2000.
14. Bravo F, Del Castillo M, Muñoz S, Portaels F. The pattern of panniculitis in Mycobacterium ulcerans infection. Am J Dermatopathol. 1999;21:74.
15. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Scott JT, et al. Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health. 2004;9:1297-304.
16. Aujoulat I, Johnson C, Zinsou C, Guédénon A, Portaels F. Psychosocial aspects of health seeking behaviours of patients with Buruli ulcer: results of a qualitative study among 130 adults and 30 children in southern Benin. Trop Med Int Health. 2003;8:750-9.
17. Johnson RC, Makoutode M, Hougnihin R, Guédénon A, Ifebe DO, Boko M, et al. Traditional treatment for Buruli ulcer in Benin [in French]. Med Trop (Mars). 2004;64:145-50.
18. Stienstra Y, van der Graaf WT, Asamoa K, van der Werf TS. Beliefs and attitudes toward Buruli ulcer in Ghana. Am J Trop Med Hyg. 2002;67:207-13.
19. Guédénom A, Zinsou C, Josse R, Andélé K, Pritze S, Portaels F, et al. Traditional treatment of Buruli ulcer in Bénin. Arch Dermatol. 1995;131:741-2.
20. Meyers WM, Portaels F. Mycobacterium ulcerans infection (Buruli ulcer). In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens, and practice. 2nd ed. Philadelphia: Churchill Livingstone Elsevier; 2006. pp. 428-35.
21. Chauty A, Ardant MF, Adeye A, Euverte H, Guédénon A, Johnson C, et al. Promising clinical efficacy of the combination streptomycin-rifampin for the treatment of Buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother. 2007;51:4029-35.
22. Mve-Obiang A, Lee RE, Portaels F, Small PLC. Heterogeneity of mycolactone toxins produced by Mycobacterium ulcerans: implications on virulence. Infect Immun. 2003;71:774-83.